Stmnt re litigation

NMT Group PLC
16 February 2001


16 February 2001

                                NMT Group PLC


                      Favourable Progress of Litigation


On 9 February 2001, the Federal Court in Indiana granted summary judgment in
favour of the Company and New Medical Technology, Inc. in respect of all
counts of patent infringement alleged by Syringe Development Partners L.L.C.
('SDP') and Medsafe Technologies L.L.C. ('Medsafe'), relative to US patent no.
5,613,952 (the 'original SDP patent'), which is held by SDP, and of which
Medsafe is the alleged sole licensee.


The Court left open for trial the issue of invalidity of the original SDP
patent.


On 13 June 2000, a new US patent no. 6,074,370 (the 'new SDP patent') was
issued to SDP. The new SDP patent is a continuation of the original SDP
patent. The Company and New Medical Technology, Inc. have filed suit in
Indiana for declaratory judgment relative to the new SDP patent on invalidity,
non-infringement and unenforceability. SDP and Medsafe subsequently filed suit
in Georgia for alleged infringement of the new SDP patent by the Company and
New Medical Technology, Inc. Following an application to the court, on behalf
of the Company and New Medical Technology, Inc., to have the infringement
action in Georgia transferred to Indiana, this has now been agreed to and
concluded, and the action has been transferred.


The infringement action and the declaratory judgment action are to be heard
before the same court as delivered the summary judgment on the original SDP
patent.


Commenting, Roy Smith, Chief Executive said:


'We are very pleased with the court's decision which supports our long-term
view that NMT's safety syringe has not infringed any of SDP's patents. We
continue to believe that the outstanding claims can also be successfully
defended.'


                                    -END-




                                  Enquiries:
NMT Group PLC
Roy Smith                                     Tel: [phone]
Financial Dynamics
David Yates/Fiona Noblet                      Tel: [phone]